Completely agree Fresh, T3 traders (T2?) bought in for a Monday morning scalp but got duped due to extension, they will be back later in the week imo!
Housekeeping continues with Unilife as Amgen want a clean skin to be a part of, 19.9% means 19.9%, not oh 19.9% now means only 19.3% because of past dealings!
Yep some numpty's are coming out of the woodwork and dreaming up anything they can to derail the threads and shed doubt everywhere. A person who works for a large corporation in a low level position might think that the company can and will just throw $15m around at free will, but the executive team and senior management would certainly beg to differ as its their a##es on the line when reporting back to stakeholders and the investment community! They aren't taking a stance on a potential drug/science here where the risks are understood by most, no they have put up $15m non refundable to enter into an agreement with a device maker, the two are worlds apart!!
UNS Price at posting:
23.0¢ Sentiment: Buy Disclosure: Held